Reaction
Cardiac Septal Defect reporting signals
As of the last recalculation, Cardiac Septal Defect appears in 715 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is MISOPROSTOL (PRR 119.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Misoprostol | 38 | 119.9 | 120.4 |
| Goserelin | 49 | 114.0 | 114.4 |
| Nicotine Polacrilex Mini | 54 | 113.2 | 113.6 |
| Nicotine Polarilex | 54 | 113.2 | 113.6 |
| Ciclesonide | 49 | 112.4 | 112.8 |
| Dalteparin Sodium | 35 | 101.2 | 101.6 |
| Bicalutamide | 48 | 98.2 | 98.5 |
| Ampicillin | 16 | 57.5 | 57.6 |
| Ampicillin Sodium | 16 | 57.5 | 57.6 |
| Sodium Bicarbonate | 42 | 55.8 | 55.9 |
| Sodium Bicarbonate Injection, | 42 | 55.8 | 55.9 |
| Nicotine | 57 | 44.5 | 44.6 |
| Nicotine Polacrilex | 54 | 44.4 | 44.4 |
| Salmeterol Xinafoate | 11 | 37.7 | 37.8 |
| Calcium Gluconate | 15 | 37.0 | 37.0 |
| Torsemide | 39 | 36.2 | 36.2 |
| Ramipril | 109 | 30.0 | 30.1 |
| Ezetimibe | 59 | 24.9 | 24.9 |
| Fluticasone Propionate And Salmeterol Xinafoate | 48 | 24.9 | 24.9 |
| Enoxaparin Sodium | 41 | 21.9 | 22.0 |
| Hydroxychloroquine | 51 | 21.3 | 21.4 |
| Brivaracetam | 6 | 19.6 | 19.6 |
| Mepolizumab | 27 | 16.4 | 16.4 |
| Riociguat | 14 | 12.7 | 12.7 |
| Vigabatrin | 3 | 6.0 | 6.0 |
| Palivizumab | 3 | 5.7 | 5.7 |